# Biological Dynamics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biological-dynamics

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.biologicaldynamics.com
- Latest round: Series C (Nov 5, 2015)
- Investors on record: 2

## About

Founded in 2010 and based in California, US, Biological Dynamics, Inc. operates as an exosome-isolation technology firm that develops diagnostic tools focused on Alzheimer's disease. The company was founded by Raj Krishnan. In October 2019, Biological Dynamics, Inc. raised USD 12 million in venture funding from unspecified investors. As of 2024, the company is led by its CEO, Paul R. Billings.

The firm’s product line includes the ExoVerita pro exosome enrichment platform, an automated system that automates and simplifies the exosome isolation process; the Verita platform uses a process called AC electrokinetics (ACE) to isolate exosomes from various biofluids like blood and plasma for downstream analysis; and the ExoLuminate platform, which focuses on early detection of pancreatic cancer using exosome-based diagnostics. The company offers exosome isolation and analysis services.

## Funding rounds

- Series C, Nov 5, 2015 — Alexandria Venture Investments, Heritage Group

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series C
- Heritage Group — Series C
